Health Care • Hospital/Nursing Management
$273.25 ▲ +2.68
(+0.99%)
MKT CAP: $21.79B • VOL: 1.21M
52W L $158 52W H $283
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$230
MEDIAN
$306
MEAN
$312
HIGH
$372
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE THC TAPE
THC // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $330.63 | $314.24 | 2025-02-14 | $248.66 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $344.30 | $322.44 | 2025-02-06 | $256.85 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $311.50 | $300.58 | 2025-01-29 | $262.32 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $278.72 | — | 2025-01-17 | $267.78 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $240.46 | $259.59 | 2025-01-09 | $243.19 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $325.17 | $284.18 | 2024-12-18 | $237.73 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $265.05 | $275.98 | 2024-12-04 | $254.12 | -4.3% | 48% | C |